Cargando…
Oxidative Stress, Nrf2, and Epigenetic Modification Contribute to Anticancer Drug Resistance
Nuclear factor E2-related factor 2 (Nrf2), a transcription factor, controls the expression of genes encoding cytoprotective proteins, including antioxidant enzymes that combat oxidative and electrophilic stress to maintain redox homeostasis. However, recent studies demonstrated that, in cancer, aber...
Autores principales: | Kang, Kyoung Ah, Hyun, Jin Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Toxicology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266370/ https://www.ncbi.nlm.nih.gov/pubmed/28133507 http://dx.doi.org/10.5487/TR.2017.33.1.001 |
Ejemplares similares
-
Particulate matter-induced senescence of skin keratinocytes involves oxidative stress-dependent epigenetic modifications
por: Ryu, Yea Seong, et al.
Publicado: (2019) -
Therapeutic aptamers: developmental potential as anticancer drugs
por: Lee, Ji Won, et al.
Publicado: (2015) -
Taxifolin Activates the Nrf2 Anti-Oxidative Stress Pathway in Mouse Skin Epidermal JB6 P+ Cells through Epigenetic Modifications
por: Kuang, Haixue, et al.
Publicado: (2017) -
Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation
por: Kang, K A, et al.
Publicado: (2014) -
Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway
por: Su, Xuling, et al.
Publicado: (2018)